-
Global Biopharma Layoffs March 2026
Layoffs
Global Biopharma companies including Merck, Baye, and Novartis announce workforce reductions in March 2026 as part of cost-saving and strategic realignments, impacting research, technology, and leadership roles across their operations.
-
Global Biopharma Layoffs November 2025
Layoffs
This article tracks recent biotech and pharma layoffs, including major workforce cuts at Novo Nordisk, Takeda, GSK, Pharming, and others, as companies restructure operations, streamline pipelines, and refocus resources amid shifting market conditions.
-
Bayer $1.3 Billion Collaboration Agreement
Bayer
Bayer and Kumquat Biosciences announce a $1.3 billion global collaboration to develop and commercialize a KRAS G12D inhibitor, aiming to offer new treatment options for pancreatic, colorectal, and lung cancer patients.
-
-
-
-
-
Bayer's 2024 Financial report
Financial statements
Bayer's 2024 financial report reveals a 2.2% revenue decline, 6,908 job cuts, and ongoing legal battles. With strategic shifts and heavy R&D investment, the company faces challenges and opportunities ahead. Can Bayer turn the tide by 2025?
-
-
澄城县|
平利县|
梅州市|
京山县|
宁德市|
中超|
楚雄市|
东明县|
太谷县|
阆中市|
文成县|
开远市|
辉南县|
水富县|
锡林郭勒盟|
龙井市|
嵩明县|
榆社县|
衡阳市|
乌恰县|
呼玛县|
田阳县|
印江|
明光市|
浑源县|
霞浦县|
通江县|
手机|
宝山区|
平邑县|
三穗县|
大兴区|
延寿县|
林州市|
年辖:市辖区|
湖州市|
平邑县|
万盛区|
若尔盖县|
平谷区|
盐山县|